| Model Number |
0684-00-0480-01U |
| Medical Device Problem Code |
Leak/Splash (1354)
|
| Health Effect - Clinical Codes |
No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
12/31/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Complete event site name: (b)(6) hospital.The product has been returned to the manufacturer, but is pending investigation.Once the investigation is completed a supplemental report with our findings will be submitted.(b)(4).
|
| |
|
Event or Problem Description
|
|
It was reported that during intra-aortic balloon (iab) therapy, a balloon rupture occurred.The iab was removed.There was no patient harm or adverse event reported.
|
| |
|
Event or Problem Description
|
|
It was reported that during intra-aortic balloon (iab) therapy, a balloon rupture occurred.The iab was removed.There was no patient harm or adverse event reported.
|
| |
|
Additional Manufacturer Narrative
|
|
The product was returned with the membrane completely unfolded with blood on the exterior and interior of the catheter and between the catheter and the sheath.The pressure tubing and extender tubing were also returned.A catheter tubing kink was observed near the y-fitting at approximately 75.9cm from the iab tip.An underwater leak test of the balloon, catheter, y-fitting, extracorporeal tubing, pressure tubing and extender tubing was performed and a leak was detected on the membrane approximately 2cm from the rear seal and measuring approximately 0.3cm in length.The problem was most likely triggered by the leak found on the membrane.Under magnification, a whitish patch was observed around the leak.This whitish patch is the typical appearance of an abrasion mark caused by a calcified plaque in the aorta.The evaluation confirmed the reported leak.A device and lot history record review was completed for the reported product.No nonconformances were found that are considered to be related to the event.The failure mode is addressed in the risk file and is operating within its risk profile.The ifu addresses the reported failure.There were no ncmrs identified which could cause or contribute to the reported failure.The investigation does not indicate that the device was inadvertently released as non-conforming or an adulterated product or was a counterfeit.The complaint history review did not identify an adverse trend (increase in number of complaints over past three (3) months).Based on the rational provided above, no escalation to the capa process is required.Reference complaint #(b)(4).
|
| |
|
Search Alerts/Recalls
|